Clinical Trials Directory

Trials / Completed

CompletedNCT01789008

Transient Elastography in the Determination of Advanced Fibrosis in Alcoholic Liver Disease.

Interest of Transient Elastography in the Determination of Advanced Fibrosis in Alcoholic Liver Didease in Alcoholic Patients in Weaning.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
300 (actual)
Sponsor
Rennes University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Alcoholic liver disease is the most frequent complication of excessive alcohol consumption. Early diagnosis of alcoholic liver disease is essential to avoid its complications that could be fatal. To date, the reference diagnostic tool is an invasive procedure: the liver biopsy. The transient elastography is a useful tool for early diagnosis of liver fibrosis. This tool is validated in the diagnosis of liver fibrosis due to C chronic hepatitis. Because it is non-invasive, fast, given immediate results; transient elastography could be repeated in alcoholic patients for liver fibrosis follow-up. In the present study, the investigators propose to realize liver biopsy and transient elastography in 300 alcoholic patients in weaning to evaluate the transient elastography accuracy in the exclusion of sever liver fibrosis (Metavir 3 and 4). The reference liver fibrosis diagnosis tool will be the liver biopsy.

Conditions

Interventions

TypeNameDescription
OTHERDetermination of Advanced Fibrosis in Alcoholic Liver Disease

Timeline

Start date
2013-02-01
Primary completion
2017-06-19
Completion
2017-08-18
First posted
2013-02-11
Last updated
2023-05-22

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT01789008. Inclusion in this directory is not an endorsement.